Your browser doesn't support javascript.
loading
Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis.
Mengyan, Xie; Kun, Ding; Xinming, Jing; Yutian, Wei; Yongqian, Shu.
Affiliation
  • Mengyan X; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Kun D; Department of Molecular Cell Biology and Toxicology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Xinming J; Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Yutian W; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Yongqian S; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Front Pharmacol ; 13: 997842, 2022.
Article in En | MEDLINE | ID: mdl-36176446
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: China Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: China Country of publication: Suiza